Cargando…
In Vitro Model for a Drug Assessment of Cytochrome P450 Family 3 Subfamily A Member 4 Substrates Using Human Induced Pluripotent Stem Cells and Genome Editing Technology
In drug development, a system for predicting drug metabolism and drug‐induced toxicity is necessary to ensure drug safety. Cytochrome P450 family 3 subfamily A member 4 (CYP3A4) is an important drug‐metabolizing enzyme expressed in the liver and small intestine, and predicting CYP3A4‐mediated drug m...
Autores principales: | Deguchi, Sayaka, Shintani, Tomohiro, Harada, Kazuo, Okamoto, Toru, Takemura, Akinori, Hirata, Kazumasa, Ito, Kousei, Takayama, Kazuo, Mizuguchi, Hiroyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369939/ https://www.ncbi.nlm.nih.gov/pubmed/34430783 http://dx.doi.org/10.1002/hep4.1729 |
Ejemplares similares
-
Establishment of SLC15A1/PEPT1-Knockout Human-Induced Pluripotent Stem Cell Line for Intestinal Drug Absorption Studies
por: Kawai, Kanae, et al.
Publicado: (2019) -
Comparison of commercially available media for hepatic differentiation and hepatocyte maintenance
por: Toba, Yukiko, et al.
Publicado: (2020) -
Efficient Generation of Small Intestinal Epithelial-like Cells from Human iPSCs for Drug Absorption and Metabolism Studies
por: Negoro, Ryosuke, et al.
Publicado: (2018) -
Generation of a bile salt export pump deficiency model using patient-specific induced pluripotent stem cell-derived hepatocyte-like cells
por: Imagawa, Kazuo, et al.
Publicado: (2017) -
Tolloid‐Like 1 Negatively Regulates Hepatic Differentiation of Human Induced Pluripotent Stem Cells Through Transforming Growth Factor Beta Signaling
por: Kiso, Ayumi, et al.
Publicado: (2020)